GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wuhan General Group (China) WUHN · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Wuhan General Group (China)

Its shares trade under the ticker WUHN. It has been listed since 1 April 1998. In the fiscal year to 31 December 2021, it reported revenue of $14,176 and a net loss of $1.7m. At that date it held total assets of $763,737 and shareholders' equity of $577,368.

Wuhan General Group (China), Inc. is a nutraceutical biotechnology company. The company is headquartered in Cape Town, Western Cape. The firm through its subsidiary MJ MedTech Inc researches, develops and commercializes a range of cannabidiol (CBD)-based products under Dr. AnnaRx and Medspresso brands. In addition, the Company also researches and develops indications for psilocybin therapies that will help patients who suffer from addiction, mental illness, Alzheimer's and Parkinson's. Its Dr. AnnaRx products are formulated with pharmaceutical premium grade CBD, all-natural ingredients and are gender neutral. The company provides CBD infused Nespresso Compatible capsule, CBD infused Immune Booster Health Shots, Mushroom infused Nespresso Compatible capsule and Mushroom infused Immune Booster Health shots. The company also provides Handcrafted Delights by Medspresso Range of Confectionary, which is a CBD infused treats made with ingredients sourced from across Africa.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
1 Apr 1998
Employees
700
Website
m2bio.co ↗

Leadership

Pay as last reported

  • Mr. Jeffrey RobinsonChief Executive Officer
  • Mr. Luka MarjanovicDirector of Human Resources and Communications, since 2020
  • Selah AbramsDirector of Corporate Strategic Partnerships
  • Rameez AdairDirector of Social Media
  • Dr. Riyad DomingoChief Innovation Officer
  • Mr. Willem JonkerChief Operating Officer - Cannabis Cultivation Project
  • Mr. Ramy KamanehConsultant, since 2017
  • Johann McLoughlinDirector of Product Development and Visual Communications and Design
  • Mr. Robert SimboweDirector of Health and Fitness
  • Dr. Anna MoreraSecretary and Chief Medical Officer, Director, since 2018

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.